Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202) - Rubenstein, JL; Hsi, ED; Johnson, JL (J Clin Oncol, 2013)
et al.